News

Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...
Some weight loss drugs may cause hair loss. While it’s typically a temporary side effect, it can affect your confidence.
Debilitating headaches are reducing their quality of life, but doctors say taking these steps can help.
In 2023, 32.69 per cent of adults in Canada (10.6 million people) were overweight with a Body-Mass Index (BMI) of 30 or ...
Some individuals living with obesity and overweight may find it difficult to embark on a weight loss journey alone. It’s not ...
A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...
Novo Nordisk seeks EMA approval for 7.2 mg Wegovy dose after trials show 21% weight loss in people with obesity and type 2 diabetes.
The drug coverage provision does not mention any specific drug by name, but it could include the GLP-1 agonists, such as ...
Wegovy, a weight loss drug, is gaining popularity for its effectiveness, but experts emphasize that it's most successful when ...
Novo Nordisk’s new weight-loss drug helped patients lose even more weight on average than its current Wegovy blockbuster treatment, an early-stage trial showed, as the drugmaker races to develop ...
Danish drugmaker Novo Nordisk on Tuesday launched its blockbuster weight-loss drug Wegovy in India, three months after Eli Lilly began marketing its rival product Mounjaro in the world's most ...
Pharmacy benefit manager CVS Caremark decided to replace Zepbound with Wegovy for use in weight loss starting July 1, despite Zepbound users having more weight loss success.